Professor (Scale II) of Oncology, Consultant Medical Oncologist 

Research Area: 

Neuro-Oncology 

Genitourinary Oncology 

Jack Gleeson is Professor (Scale II) of Oncology at University College Cork (UCC) and a Consultant Medical Oncologist at Cork University Hospital / University College Cork Cancer Centre. He is a UCC graduate (2012, Hons) who completed his Medical Oncology training in Ireland through the RCPI before being awarded the Irish Society of Medical Oncology (ISMO) Advanced Oncology Fellowship award in 2018 to undertake a fellowship in Memorial Sloan Kettering Cancer Center (MSKCC), New York, which he completed in January 2021. He subsequently worked as a Consultant Medical Oncologist in CUH (locum, 2021) and Consultant Medical Oncologist in Kidney and Hepatobiliary cancers at The Christie hospital in Manchester, UK (2022) before returning to his current role in March 2023.  

He has had a distinguished career to date with numerous publications and awards, including the UCC Ainsworth Scholarship, Merit Awards at the ASCO GU Cancers Symposium and International Kidney Cancer Symposium, as well as the prestigious ASCO/Conquer Cancer Foundation Young Investigator Award (YIA) for 2021/2022 and the Irish Cancer Society Networking Award 2024.  

Research 

Prof. Gleeson is particularly interested in Neuro-Oncology research, and is both the local Neuro-Oncology MDM Co-Chair and Central Nervous System (CNS) disease-specific subgroup co-chair for Cancer Trials Ireland. He leads observational/translational and interventional clinical trials, and established the regional Brain Tumour Research Network group which stimulates collaboration between senior researchers from the University and Hospital settings.  

His genitourinary research to date primarily focused on kidney and testicular cancers, but he is also involved with prostate, urothelial and pan-genitourinary cancer research. Having trained at the world-renowned cancer centres of both Memorial Sloan Kettering in New York and The Christie in Manchester, Prof. Gleeson has gained significant research experience in trial design and development with world class experts in the field.  

Patient-focused research is at the core of our mission. Prof Gleeson has a particular focus on predicting response to treatment and treatment efficacy, and the development of novel therapies for cancers with limited treatment options such as Glioblastoma (GBM). 

Funders 

American Society of Clinical Oncology (ASCO) 

Conquer Cancer Foundation 

Irish Cancer Society